MTaI in News

Overview of 2018 for med-tech and expectations for 2019

Overview of 2018 for med-tech and expectations for 2019

  With the value of Indian MedTech Industry expected to reach 9.5 billion dollars in the next 4 years from the current value of 6.3 billion dollars, the MedTech industry has been recognized as a sunrise sector. By Pavan Choudary 2018 has been a mixed year for the...

read more
MTaI welcomes government’s decision to create NMDPC

MTaI welcomes government’s decision to create NMDPC

Global companies support the Make-in-India program and expect a fair opportunity to contribute to the Indian patients with their global products and have proved their worth time and again Medical Technology Association of India supports central government’s decision...

read more

MTaI seeks one time increase of 18% in MRP of medical device

New Delhi, Nov 20 - Medical Technology Association of India (MTaI) Tuesday asked the government to allow a one-time increase of up to 18 per cent in maximum retail prices (MRPs) of medical devices, including stents and orthopedic knee implants, in order to offset the...

read more
AN IDEAL ROADMAP TO STRENGTHEN MEDTECH IN INDIA

AN IDEAL ROADMAP TO STRENGTHEN MEDTECH IN INDIA

By Probir Das Medical Technology, often referred to just as medical devices, is a critical pillar of advanced healthcare delivery throughout the world. In India till recently, medical devices had not gotten appropriate attention from policy designers. Currently...

read more
MedTech – Vitalizing Ayushman Bharat

MedTech – Vitalizing Ayushman Bharat

For ensuring the takeoff of AB-PMJAY, the MedTech industry has a huge responsibility. Huge financial resources and investments at various levels, with government support is one of the major pre-requisites, and this leap is an essential condition for its success....

read more
MTaI points out ill-information on needles, syringes pricing

MTaI points out ill-information on needles, syringes pricing

There has been no advisory from NPPA on reducing high margins on needles and syringes so far. We have studied the stories in media recently and found them ill-informed and wrong at multiple places especially the mention of our member companies Becton Dickinson, and B...

read more
The many challenges ahead of Ayushman Bharat

The many challenges ahead of Ayushman Bharat

Free healthcare doesn’t necessarily mean quality healthcare — and Indians are ruthless with their expectations of quality. Say you are the government. How do you know a mega scheme meant to lift millions from suffering isn’t panning out the way you wanted? When it...

read more